Status:

COMPLETED

Yale COVID-19 Recovery Study

Lead Sponsor:

Yale University

Collaborating Sponsors:

Food and Drug Administration (FDA)

Conditions:

Covid19 Sequelae

Eligibility:

All Genders

18+ years

Brief Summary

The general purpose of the study is to determine the change in immune responses in people with Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) after vaccination. PASC is a disabling, heterogeneous ...

Detailed Description

The investigators are conducting an observational study within Connecticut of adults who have moderate-to-severe PASC and who are planning to receive a vaccine against SARS-CoV-2. The study seeks prim...

Eligibility Criteria

Inclusion

  • Fluent in English or Spanish
  • Age 18 years and over
  • Test positive for SARS-CoV-2 (defined as a patient who reports receiving any screening or diagnostic test used to detect the presence of SARS-CoV-2 including any FDA-approved or authorized molecular or antigen-based assay) at least 2 months prior to the start of this study OR test positive for antibodies to SARS-CoV-2 at any point OR receive a positive T-test at any point OR receive a clinical diagnoses of COVID-19 at any point OR was hospitalized due to COVID-19 at any point
  • Self-report moderate to severe symptoms or disability due to PASC
  • Self-report planning to receive a vaccine against SARS-CoV-2
  • Self-report has not yet received any doses of a vaccine against SARS-CoV-2

Exclusion

  • Unable to provide informed consent
  • Unable to provide 3 blood and saliva samples at one of the 2 participating Yale New Haven Health blood draw sites on a Monday or Wednesday morning (before 12 pm).
  • Does not have access to a hand-held device or computer that would allow for digital participation in the study
  • Do not have and do not want to set up an email address
  • Individuals who are prisoners

Key Trial Info

Start Date :

May 3 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 9 2025

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT04895189

Start Date

May 3 2021

End Date

May 9 2025

Last Update

May 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Yale New Haven Hospital

New Haven, Connecticut, United States, 06510

Yale COVID-19 Recovery Study | DecenTrialz